Search Result "5q- syndrome"
5q- syndrome
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3180-3183
Author(s): Jacqueline Boultwood,Andrea Pellagatti,James S. Wainscoat
Lenalidomide for Treatment of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3198-3203
Author(s): Rami S. Komrokji,Alan F. List
Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 339-342
Author(s): Vishakha Kale, Alan F. List
Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes
Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 713-725
Author(s): E. H. Lindberg
Biological Basis of Novel Therapies for Myelodysplastic Syndrome
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 199-209
Author(s): Eyal C. Attar, Karen K. Ballen
Role of Immunomodulatory Drugs in the Treatment of Lymphoid and Myeloid Malignancies
Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Ota Fuchs
Doi: 10.2174/9781681083674118030005
MicroRNA Dysregulation in the Myelodysplastic Syndromes
Journal: MicroRNA
Volume: 2 Issue: 3 Year: 2013 Page: 174-186
Author(s): Stephen S. Chung,Christopher Y. Park
World Health Organization Classification of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3149-3162
Author(s): Magdalena Czader,Attilio Orazi
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 51-78
Author(s): Ota Fuchs
Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3204-3214
Author(s): Takayuki Tsujioka,Akihito Matsuoka,Yumi Tohyama,Kaoru Tohyama